Nanoco Group PLC Directorate Change (7890C)
April 20 2017 - 2:01AM
UK Regulatory
TIDMNANO
RNS Number : 7890C
Nanoco Group PLC
20 April 2017
Nanoco Group plc
("Nanoco" or the "Company")
Directorate Change
Nanoco Group plc (LSE: NANO), a world leader in the development
and manufacture of cadmium-free quantum dots and other
nanomaterials, is pleased to announce the appointment of Dr Alison
Fielding as a Non-executive Director with effect from 20 April
2017.
Alison is Director of Strategy and IP Impact at IP Group and is
currently a Non-executive Director of Getech Group plc. She holds
an MBA from Manchester Business School, a PhD in organic chemistry
and a first-class degree in chemistry from the University of
Glasgow. Alison started her career at Zeneca PLC (now Astra Zeneca)
followed by five years at McKinsey & Company and later
co-founded Techtran Group Limited which was acquired by IP Group in
2005 where she held the role of director and COO until 2013. Whilst
at IP Group, she also sat on the board of and advised several early
stage and quoted IP Group backed technology companies.
Alison's appointment follows the announcement in January that
Robin Williams would stand down as a Non-executive Director in July
due to other commitments. Alison will succeed Robin as Chair of the
Audit Committee on 13 July 2017. She will also be a member of the
Remuneration Committee.
Dr Christopher Richards, Nanoco's Chairman, said: "Alison brings
an exceptional breadth of relevant skills to the Nanoco Board, with
her background in chemistry and her extensive commercial, financial
and international experience across the technology sector. Her
appointment will strengthen the Board significantly as we move
forward to commercial success and her extensive Board experience
will also reinforce Nanoco's continued commitment to
governance."
Alison has been a director of several publicly quoted companies,
including Fusion IP plc, hVIVO plc, IP Group plc and Tissue Regenix
Group plc.
The Company confirms that there is no additional information
which is required to be disclosed under Rule 9.6.13 of the Listing
Rules of the UK Listing Authority.
For further information, please contact:
Nanoco Tel: +44 (0) 161 603
7900
Michael Edelman, Chief
Executive Officer
David Blain, Chief Financial
Officer
Caroline Watson, Investor Tel: + 44 (0) 7799
Relations Manager 897357
cwatson@nanocotechnologies.com
Peel Hunt Tel: +44 (0) 20 7418
8900
Adrian Trimmings
George Sellar
Alex Lomax
MHP Communications Tel: +44 (0) 20 3128
8100
Reg Hoare / Andrew Leach
/ Giles Robinson / Peter
Lambie
Nanoco@mhpc.com
About Nanoco Group plc
Nanoco is a world leader in the development and production of
cadmium-free quantum dots and other nanomaterials for use in
multiple applications including LCD displays, lighting, solar cells
and bio-imaging. In the display market, Nanoco has non-exclusive
manufacturing and marketing licensing agreements with The Dow
Chemical Company, Merck KGaA and Taiwan's Wah Hong Industrial
Corporation. Nanoco also has a strategy of direct sales in display
and in its other target markets, including lighting.
Nanoco was founded in 2001 and is headquartered in Manchester,
UK. It has production facilities in Runcorn, UK, and a US
subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has
business development executives in Japan, Korea and Taiwan. Its
technology is protected worldwide by a large and growing patent
estate.
Nanoco is listed on the main market of the London Stock Exchange
and trades under the ticker symbol NANO. For further information
please visit: www.nanocogroup.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOALLFLDSTIALID
(END) Dow Jones Newswires
April 20, 2017 02:01 ET (06:01 GMT)
Nanoco (LSE:NANO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nanoco (LSE:NANO)
Historical Stock Chart
From Apr 2023 to Apr 2024